While we believe that a delay is not justified, we will use the opportunity presented by the FDA proceedings to continue to press for approval of Plan B as an OTC/Rx Product.
We review these patents for validity and of course there's a lot of incentives on the other side to press the patent to the bursting point,
we will ... continue to press for approval of Plan B as an over-the-counter/ prescription product.
We are disappointed that the FDA did not approve our application. While we believe that a delay is not justified, we will use the opportunity presented by the FDA proceedings to continue to press for approval of Plan B as an OTC/Rx Product.